Mutual of America Capital Management’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-3,652
| Closed | -$34K | – | 1689 |
|
|
2020
Q3 | $34K | Buy |
3,652
+1,964
| +116% | +$18.7K | ﹤0.01% | 1602 |
|
|
2020
Q2 | $13K | Buy |
1,688
+208
| +14% | +$1.59K | ﹤0.01% | 1617 |
|
|
2020
Q1 | $9K | Buy |
1,480
+267
| +22% | +$2.35K | ﹤0.01% | 1612 |
|
|
2019
Q4 | $15K | Sell |
1,213
-33
| -3% | -$361 | ﹤0.01% | 1618 |
|
|
2019
Q3 | $14K | Buy |
1,246
+27
| +2% | +$284 | ﹤0.01% | 1624 |
|
|
2019
Q2 | $12K | Buy |
1,219
+220
| +22% | +$2.37K | ﹤0.01% | 1635 |
|
|
2019
Q1 | $13K | Buy |
999
+142
| +17% | +$2.12K | ﹤0.01% | 1612 |
|
|
2018
Q4 | $13K | Buy |
857
+208
| +32% | +$3.96K | ﹤0.01% | 1575 |
|
|
2018
Q3 | $13K | Buy |
649
+523
| +415% | +$11.9K | ﹤0.01% | 1583 |
|
|
2018
Q2 | $2K | Buy |
+126
| New | +$2.79K | ﹤0.01% | 1649 |
|
|
2016
Q2 | – | Sell |
-1,200
| Closed | -$28K | – | 1239 |
|
|
2016
Q1 | $28K | Hold |
1,200
| – | – | ﹤0.01% | 1207 |
|
|
2015
Q4 | $36K | Buy |
1,200
+300
| +33% | +$9.69K | ﹤0.01% | 1202 |
|
|
2015
Q3 | $36K | Buy |
+900
| New | +$55.9K | ﹤0.01% | 1211 |
|
Mutual of America Capital Management's AMAG Position: Q4 2020 in Review
Mutual of America Capital Management sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 3,652 shares — an estimated $34K sold.
Mutual of America Capital Management first reported a position in AMAG in Q3 2015 and held it in 13 quarters. The position peaked at $36K in Q4 2015. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Mutual of America Capital Management reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Mutual of America Capital Management sold 3,652 AMAG Pharmaceuticals shares in Q4 2020, an estimated $34K.
- Mutual of America Capital Management first reported a position in AMAG Pharmaceuticals in Q3 2015 and held it in 13 quarters.
- Mutual of America Capital Management's AMAG Pharmaceuticals position peaked at $36K in Q4 2015.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Mutual of America Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.